Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EQL Pharma AB ( (SE:EQL) ) has shared an update.
EQL Pharma AB has announced its upcoming annual general meeting, scheduled for August 21, 2025, at its premises in Lund. The agenda includes key resolutions such as the election of the Chairman, approval of financial statements, and a decision on a long-term incentive program for the CEO. The board proposes no dividends, opting to carry forward available funds, indicating a focus on reinvestment and growth.
More about EQL Pharma AB
Average Trading Volume: 18,259
Current Market Cap: SEK2.58B
Learn more about EQL stock on TipRanks’ Stock Analysis page.